TGFB1 and breast carcinoma: Elevated levels of TGF-β1 in advanced-stage breast cancers were associated with tumor size, decreased tumor cell differentiation, epithelial to mesenchymal transition (EMT), and increased metastasis to axillary lymph nodes [14,15,16,17,18].